Laura Smith University of Cincinnati. June 7 th, 2012

Similar documents
Vishwanath Pattan Endocrinology Wyoming Medical Center

Diabetes in Pregnancy

Management of Pregestational and Gestational Diabetes Mellitus

Diabetes AN OVERVIEW. Diabetes is a disease in which the body is no longer

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

Diabetes in Pregnancy

Maternal and Fetal Complications in Diabetes Pregnancy

Diabetes in Pregnancy

Diabetes in Pregnancy. L.Sekhavat MD

DIABETIC MOTHERS; FREQUENCY OF MACROSOMIA AND HYPOGLYCEMIA IN NEONATES OF (CONTROLLED VERSUS UNCONTROLLED).

A S Y N T H E S I Z E D H A N D B O O K ON G E S T A T I O N A L D I A B E T E S

Early life influences on adult chronic

Gestational Diabetes. Gestational Diabetes:

Are Novel Lifestyle Approaches to Management of Type 2 Diabetes Applicable to Prevention and Treatment of Women with Gestational Diabetes Mellitus?

Objectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)

Pregestational and Gestational Diabetes

Effect of Various Degrees of Maternal Hyperglycemia on Fetal Outcome

Pregnancies complicated by diabetes. Marina Mickleson Nurse Practitioner Midwife CDE

Lessons from conducting research in an American Indian community: The Pima Indians of Arizona

2018 Standard of Medical Care Diabetes and Pregnancy

Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016

Am I at Risk for Type 2 Diabetes?

Diabetes. For Institute for Healthy Aging at Keiro. Take Time To Care

R. Leibel Naomi Berrie Diabetes Center 19 March 2010

Looking Toward State Health Assessment.

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Data from birth certificates in the United

DIABETES WITH PREGNANCY

The Ever-Changing Approaches to Diabetes in Pregnancy

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

Metabolic Programming. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD

Current Trends in Diagnosis and Management of Gestational Diabetes

Moving Gestational Diabetes Care into the Community

Approximately one third of the 15.7 million Americans who are estimated to have diabetes

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Management of Gestational Diabetes

Prevention and Management of Diabetes in Pregnancy

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

WDF Indicator catalogue

Early Origins of Metabolic Disease and Aging

Diagnosis and Management of Gestational Diabetes Mellitus. Prof. Dr Md Faizul Islam Chowdhury Professor of Medicine, Department of Medicine, DMCH.

Peripartum and Postpartum Management of Diabetes

Page # 1. Objectives. History of Clinical Trials. Developing New Therapies Clinical Studies and Trials. FDA Classification of Clinical Studies/Trials

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control

10/9/2017 OBJECTIVES DIABETES REVIEW

What is gestational diabetes?

Continuous or Intermittent Glucose Monitoring in Interstitial Fluid

Hypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier??

Figure 2.1: Glucose meter

Hypoglycemia. Objectives. Glucose Metabolism

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Common Diabetes-related Terms

Effective Health Care Program

Guideline for Management of Type 2 Diabetes Mellitus: Kingdome of Bahrain Ministry of Health 2016

Diabetes Overview. How Food is Digested

Diabetes Prevention in. Massachusetts: Prediabetes and the Diabetes Prevention Program. Diabetes Prevention and Control

Diabetes Related Disclosures

GESTATIONAL DIABETES for GP Obstetric Shared Care Accreditation Seminar. Simon Kane March 2016

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

PES Recommendations for Evaluation and Management of Hypoglycemia in Neonates, Infants, and Children Paul S. Thornton On behalf of the Team

Standards of Medical Care in Diabetes 2016

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

Merck & Co, Inc. Announced Approval of JANUVIA TM (INN: sitagliptin), a new oral treatment of diabetes, by the US FDA

Collaboration Between WIC and EHDI to Improve Follow-Up of Newborn Hearing Screening in Greater Cincinnati

Diabetes in pregnancy

Secular Trends in Birth Weight, BMI, and Diabetes in the Offspring of Diabetic Mothers

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network

Oral glucose lowering agents in gestational diabetes. Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France)

What Degree of Maternal Metabolic Control in Women With Type 1 Diabetes Is Associated With Normal Body Size and Proportions in Full-Term Infants?

Objectives. Medical Complications of Pregnancy. Potential Conflicts: None. Common Complicating Medical Conditions that Precede Pregnancy

Diabetes and pregnancy

Ketonemia and ketonuria in gestational diabetes mellitus

Managing Diabetes Before, During, and After Pregnancy

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Project LIM Lifestyle Interventions Matter

Position Statement of ADA / EASD 2012

The Aboriginal Maternal and Infant Health Service: a decade of achievement in the health of women and babies in NSW

Demonstration to Maintain Independence and Employment University of Hawai`i - Center on Disability Studies Pacific Rim Conference April 14, 2008

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Original Article. Keiko KOHNO 1), Kazuhiko HOSHI 1), Motoi TAKIZAWA 1), Takashi KANEKO 2), and Shuji HIRATA 1)

APPENDIX American Diabetes Association. Published online at

Chapter 1 - General introduction.

Diabetes - The Facts

V. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof.

Ott et al. BMC Pregnancy and Childbirth (2018) 18:250 (Continued on next page)

Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE

Glycemic Control IU Health Diabetes Centers

Am I at Risk for Type 2 Diabetes?

Diagnosis of Diabetes National Diabetes Information Clearinghouse

Insulin therapy in gestational diabetes mellitus

Pregnancy outcomes in Korean women with diabetes

GESTATIONAL DIABETES TESTING AND TREAMENT

Request for Applications Basic, Clinical and Population Science Pilot Awards

New Guidelines for the Diagnosis of Diabetes Mellitus

Pregestational Diabetes in Pregnancy. An Update

Transcription:

Laura Smith University of Cincinnati June 7 th, 2012

1. Background 2. Grant 3. Research Strategy

Background

Practical /Relevant Useful skill Filled a need

25.8 million in the U.S. (2011) A leading cause of: heart disease, stroke, kidney disease, neuropathy, amputation, blindness etc. Medication (insulin and oral), diet and monitoring blood glucose are standards of care Daily blood glucose: 3-4 x per day HbA1C: 2 x a year (or more if necessary)

Test Target Blood Glucose Fasting Before Meals 1-2 hours After Meals 90-130 mg/dl (5-7mmol/L) 70-130 mg/dl (4-7mmol/L) <180 mg/dl (10mmol/L) HbA1C < 6.5%

Diabetes is more complex during pregnancy as there is a risk of adverse maternal and neonatal outcomes Hypo- and hyperglycemic states are known to be associated with type-i diabetes during pregnancy Higher rates of adverse outcomes in type-i diabetic pregnancies than non-diabetic pregnancies Includes maternal, neonatal and offspring outcomes Preeclampsia, premature labor, premature delivery, infection. abnormal birth weight, minor congenital malformation, hypoglycemia. Obesity, insulin resistance, beta cell dysfunction and diabetes, renal and cardiovascular dysfunction, altered neurocognitive function.

Regardless of that Women with pre-gestation type- I diabetes continue have considerably higher proportions of adverse maternal and neonatal outcomes than non-diabetic pregnancies This indicates a gap!

Previous studies have examined glucose control during pregnancy, however. Used mean glucose concentrations How to identify problem periods w/ mean data? Used short term continuous monitoring Inconvenience, QoL

Diabetes in Pregnancy Program Project Grant (PPG) Jane Khoury et al NIH Funded UC and CCHMC 1978-1995 341 women; 439 pregnancies

The purpose of the PPG was to: Collect maternal glucose control data Collect neonatal weight and blood glucose Daily capillary blood glucose monitoring (CBGM) 4-6 x per day Glycohemoglobin (HbA 1 ) Monthly

Instructed to measure their glucose: before each meal, 90-minutes after each meal, at bedtime and at 3am throughout pregnancy Managed with intensive insulin therapy, involving a split mixed-dose regimen of three to four injections per day using short- and intermediateacting insulin combined with dietary regulation Goals of glycemic control were: less than 5.55 mmol/l for fasting less than 7.77 mmol/l for 90 minute postprandial

Follow-up studies: 1. Use of functional data analysis (semiparametric regression) to compare maternal and neonatal outcome data from PPG Assessed time specific differences in glycemic profiles Identified the first and third trimesters as periods of gestation where maternal glucose concentrations differ for large for gestational age (LGA) (90%) and appropriate for age (AGA) fetuses

Follow-up studies (cont): 2. Pilot study to track the offspring of women from the PPG Assess the effect of level of maternal glucose control during pregnancy on long-term outcome of the offspring, by assessing the ability to locate and recruit the offspring 19 participated Glucose tolerance testing, BMI, dual x-ray absorptiometry and blood pressure

Grant

R-21 NIH Exploratory/Developmental Research Grant Award Encourages new, exploratory and developmental research projects by providing support for the early stages of project development 2 years $275K Cost effective

Secondary Analysis in Obesity, Diabetes and Digestive Kidney Diseases (PA-12-125) the goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) $275,000 for 2 years Posted March 19 th, 2012 Opened May 16 th, 2012 PA-12-125

Encourages applications that are: Innovative Explore existing data sets Analysis that shapes/informs future studies Novel approaches/methodologies Interventions

Research Strategy

Specific Aim 1. Using advanced statistical strategies, identify and characterize the degree and timing of gestational glycemic dysfunction on the risk of maternal complications and adverse neonatal and offspring outcomes Specific Aim 2. Evaluate the impact of adherence to glucose selfmonitoring on glycemic control measured as daily glucose concentration and monthly glycohemoglobin A1 Specific Aim 3. Develop HBM based pilot intervention to address the gestational time-specific associations of poor glucose adherence and adverse maternal, neonatal and offspring outcomes

SA #1: Functional data analysis Expansion of preliminary semi-parametric regression study using PPG data Type I diabetes Monitored glucose throughout pregnancy Delivered single, live fetus, > 32 weeks

SA #1: Functional data analysis Expected outcomes: expect that we will be able to once again identify crucial times during pregnancy associated with risks for maternal and neonatal morbidities association not causality

SA #2: Pilot Study Expansion Expand Pilot Study to include remaining offspring Waived consent Name, DOB, Phone number Electronic Medical Records (EMR) Diagnostic Codes growth, adiposity, fasting glucose, insulin levels (diabetes/renal) and cardiovascular status

SA #2: Pilot Study Expansion Expected outcomes: Offspring with successfully located codes will be associated with women from PPG who had uncontrolled glucose during gestation Elucidate impact of the importance of glucose monitoring adherence during pregnancy

SA #2: Pilot Study Expansion Potential problems: 1. Locating EMR 2. Connecting EMR to PPG mothers 3. Bias

SA # 3: Develop time-specific intervention Use of preliminary data, SAs #1 and #2 and the Health Belief Model (HBM) to develop pilot intervention Pilot intervention could be applied at time-specific periods of gestation as indicated from the semiparametric regression Forecasted use in a clinical setting

SA # 3: Develop time-specific intervention HBM Developed for health related behaviors 6 constructs perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action and selfefficacy Applications in Diabetes Adherence to medical therapy/metabolic control

SA # 3: Develop time-specific intervention Expected outcomes: Interim analysis will reveal the need for educational process for perceived severity, perceived benefits and self efficacy (minimum) Perceived barriers? Can these be changed? Successful development of a pilot intervention would allow for further study of glucose monitoring adherence on a new population of women with type I diabetes in pregnancy and eventual use in a clinical setting

Educational Constructs Behavioral Behavioral Process of HBM Objectives Outcome How to modify? Severity -mention negative consequences -personalize seriousness Benefits -positive benefits Self Efficacy -Use of small steps -demonstration -reinforcement

SA # 3: Develop time-specific intervention Potential Problems: Use of HBM in this setting Primary and Secondary prevention Long term behavior change Alternative Strategies: Use of a different theory if necessary?

2 year period beginning in September 2012 Apply for Institutional Review Board approval prior to the award announcement Data Analysis EMR Review Development of Pilot Intervention Results Conferences/Publications

Table 1. Grant Timetable Year 1 Year 2 Quarter of Year 1 2 3 4 1 2 3 4 Early IRB approval x Weekly Team Meetings x x x x x x x x Interim Functional data analysis x x x x x Offspring EMR Chart review and follow up x x x x x Development of Pilot Intervention x x x x x Present early results at conferences x x Final Analysis x x Publications Ongoing after last year x x

Employee Role (% effort) Year 1 Salary Year 2 Salary Total PI PI (20%) $21,800 $22,500 $44,300 PI PI (10%) $13,500 $13,900 $27,400 Co-PI Co-I (5%) $9,200 $9,500 $18,700 Coordinator Co-I (40%) $17,500 $18,000 $35,500 Statistician Data Mgmt (10%) $9,300 $9,500 $18,800 Graduate Student GradStudent (100%) $36,200 $37,300 $73,500 = $218,200 Fringe $50,000 Travel $6,000 =$274,200

We anticipate that results from this proposal will enhance subsequent extramural applications Early identification of children at risk for morbidity, and potential intervention during early childhood Insights into later outcomes

Great learning experience! Teamwork Time management Writing skills

Dr. Liliana Rojas-Guyler Dr. Rebecca Vidorek Dr. Jane Khoury Dr. Rhonda VanDyke Dr. Jareen Meinzen-Derr